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Abstract According to a 2010 national survey, 11% of adults
in China have diabetes, affecting 109.6 million individuals.
The high prevalence of diabetes has been attributed to the
aging of the population, the rapid adoption of energy-dense
foods, and a reduction in physical activity. Collectively, these
secular changes have created an obesogenic environment that
can unmask diabetes in subjects with a genetic predisposition.
The growing prevalence of maternal obesity, gestational dia-
betes, childhood obesity, and early-onset disease can lead to
premature morbidity and mortality. Rising to meet these pub-
lic health challenges, researchers in China have conducted
randomized studies to demonstrate the benefits of lifestyle
modification in preventing diabetes (the Da Qing Study), as
well as that of team-based integrated care, using multiple strat-
egies including peer support and information technology, in
order to reduce hospitalizations, cardiovascular-renal compli-
cations, and premature deaths. With growing evidence
supporting the benefits of these diabetes prevention and man-
agement programs, the next challenge is to use policies and
systems to scale up the implementation of these programs
through raising awareness, building capacity, and providing
resources to reduce the human and socioeconomic burden of
diabetes.
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Introduction: Diabetes in China
Between 1950 and 1960, China has undergone a period of
post-war social hardship followed by a period of famine be-
tween 1959 and 1961, and then a long period of social up-
heaval. In the 1980s, the Chinese Government initiated a se-
ries of political and economic reforms that have resulted in
phenomenal socioeconomic growth, technological advance-
ment, and cultural changes. The gross domestic product
(GDP) increased from 365 billion RMB in 1978 to 56,885
billion RMB in 2013 [1]. With socioeconomic growth, the
malnutrition and physical labor experienced in the 1950–
1960 was replaced by overconsumption of calories and exten-
sive use of automobiles. These rapid changes in lifestyle are
believed to have contributed to the dramatic increase in dia-
betes prevalence from 0.9 % in 1980 [2] to 11.6 % in 2010
[3•]. Together with the prevalence of gestational diabetes of
8.1 %–10.9% [4, 5] and childhood obesity of 5.5 % [6], early-
onset type 2 diabetes has emerged as a major public health
challenge associated with premature morbidity and mortality
[7]. This is compounded by an aging society with increasing
frailty, which can be amplified by the comorbidities of diabe-
tes in China [8].
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General and Central Obesity
In Asia, the rising prevalence of obesity and metabolic syn-
drome are major drivers for the increasing incidence [9] and
prevalence of diabetes [10–13]. The risk association between
body mass index (BMI) and diabetes is particularly robust in
individuals below the age of 50 years [14]. Obesity is also an
independent risk factor for cardiovascular morbidity and mor-
tality [15]. In a meta-analysis, each 5 kg/m2 increase in BMI is
associated with 27 % increased risk of coronary heart disease
and 18 % increased risk of stroke [16], the latter being the
leading cause of death in Asian populations [17]. The rapid
lifestyle changes associated with urbanization in China is
characterized by high caloric intake and reduced physical ac-
tivity [18], putting Chinese people at high risk of obesity [19].
The prevalence of adult overweight (BMI ≥25 kg/m2) has
tripled from 11.7 % in 1991 to 29.2 % in 2009 [20]. Without
new public health interventions, by 2030, the prevalence of
overweight and obesity are expected to reach 59.7 % and
12.6 %, affecting 669.2 million and 141.2 million people,
respectively [20].
Compared with BMI, which is a crude estimate of general
obesity, central obesity measured by waist circumference
(WC) is a stronger predictor for diabetes in Asia. In Chinese
adults aged 18 to 65 years, the mean BMI had increased from
21.5 kg/m2 in 1991 to 22.9 kg/m2 in 2011, whereas the mean
WC had increased from 74.5 cm in 1993 to 80.5 cm in 2011
[20]. For the same BMI, Asian people are more likely to
develop diabetes than their Caucasian counterparts, in part
due to their tendency to accumulate visceral fat, as reflected
by high WC. This ectopic adiposity is associated with abnor-
mal profile of adipokines (eg, low adiponectin) and low grade
inflammation (eg, high sensitive C reactive protein), which
can cause insulin resistance to unmask diabetes in people with
beta cell insufficiency [13, 21]. In Chinese adults, central obe-
sity is a stronger predictor than BMI for coronary heart dis-
ease, diabetes, and metabolic syndrome [22–24]. In a 6-year
prospective survey, increasedWCwas associated with 3- to 5-
fold increased risk of type 2 diabetes [13]. In a recent study
that compared the effect sizes of BMI and WC on health
outcomes in Chinese adults, central obesity was associated
with increased risk of incident hypertension within normal
BMI category. The authors concluded that if only BMI was
measured, more than 65 % of people at risk would have been
missed [25].
Diabetes in Young People
In a 2010 Chinese national survey, the prevalence of type 2
diabetes was 4.5 % in people aged 18–29 years and 6.6 % in
those aged 30–39 years. In people under the age of 40 years,
40 %–50 % had prediabetes [3•]. In Taiwan and Hong Kong,
type 2 diabetes has overtaken type 1 diabetes as the predom-
inant form of diabetes in children [21], similar to that in the
West [26]. Early-onset type 2 diabetes substantially increases
the risk of premature mortality andmultiple morbidities in part
due to long disease duration [7, 27] and suboptimal manage-
ment [28]. In patients with type 2 diabetes diagnosed between
the age of 15 and 24 years, the l ifet ime risk of
microalbuminuria approached 100 %, whereas that of blind-
ness was 20 % with an estimated reduced lifespan of 15 years
[29].
In China, the rapid nutritional transition in recent decades
has major health hazards on both mothers and their offspring.
During the famine period of 1959–1961, many women who
had suboptimal nutrition during pregnancy gave birth to chil-
dren who were subsequently exposed to high-fat, calorie-
dense diets after birth. In this regard, these offspring had dual
exposure to maternal undernutrition followed by childhood
and adult overnutrition. Compared with their counterparts
born outside this period, offspring of mothers who were preg-
nant during the famine had 3.9 times increased risk of diabetes
or hyperglycemia [30]. This risk was further increased if the
offspring had high socioeconomic status later in life or was
overweight [30]. These subjects with early-onset type 2 dia-
betes have high risk of complications due to long disease
duration [7, 27]. Yet according to the latest national survey,
only 30 % of subjects were diagnosed, and amongst the diag-
nosed only 25 % were treated, and amongst those treated only
40 % were controlled using a HbA1c of 7 % as recommended
target [3•]. Compared with the patients with late-onset diabe-
tes, patients with early-onset diabetes often have suboptimal
control of risk factors. These undesirable situations are, in
part, due to the silent nature of diabetes and, in part, competing
priorities with many young patients being non-adherent and
disinclined to have regular medical follow-up visits. Besides,
these patients are also less likely to receive intensive treatment
despite harboring risk factors and complications resulting in
disabilities and premature death [7, 27, 31]. With increasing
rates of obesity and physical inactivity among young people
across the globe, early-onset type 2 diabetes has become a
serious public health issue, calling for urgent actions to detect
them early for intervention including regular surveillance and
targeted programs.
Gestational Diabetes Mellitus in China
Gestational diabetes mellitus (GDM) is an important but often
overlooked risk condition affecting many women and their
offspring. In 2015, more than 20 million live births were af-
fected by diabetes during pregnancy, which accounted for
16.2 % of live births [32]. In China, the Ministry of Health
has recommended that providers adopt the diagnostic criteria
of GDM based on the International Association of the
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Diabetes and Pregnancy Study Groups (IADPSG) guidelines
since December 2011 [33]. Using these criteria, in 2011,
10.9 % of a cohort of 6201 pregnant Chinese women had
GDM [4]. In Tianjin, the fourth largest city of China, which
provides universal screening for GDM, the prevalence of
GDM has increased from 2.3 % in 1999 to 6.8 % in 2008
and 9.3 % in 2012. However, the magnitude of the problem
remains uncertain due to lack of national data [5].
Abnormal glucose tolerance during pregnancy predisposes
mother and offspring to metabolic syndrome and type 2 dia-
betes in later life. On average, women with GDM had more
than 7-fold increased risk of developing type 2 diabetes than
those with normoglycemia during pregnancy [34]. On the
other hand, fetal exposure to intrauterine hyperglycemia is
associated with abnormal insulin secretory responses and in-
creased risk of early-onset diabetes, independent of genetic
susceptibility and maternal diabetes types [35, 36]. While ma-
ternal obesity, GDM, childhood obesity, as well as early-onset
diabetes and chronic diseases are global challenges, these sec-
ular trends are particularly stark in developing countries like
China [37]. In the latest World Health Organization Global
Monitoring Framework for Noncommunicable Disease
(NCD), a life-course intervention targeting women and chil-
dren is one of the approaches recommended for the prevention
of diabetes and NCD [38].
Diabetes Prevention and Care Programs in China
Since the late 1980s, researchers in China have conducted
a series of trials of interventions, with original designs or
adaptations from other international studies, to prevent the
onset of diabetes and its complications in order to reduce
the disease burden.
Lifestyle Intervention in High-Risk Subjects
The Da Qing Diabetes Prevention Program was the first ran-
domized study conducted in China to demonstrate the benefits
of lifestyle modification on reducing the risk of progression
from impaired glucose tolerance (IGT) to diabetes [39]. After
6 years of active intervention, the risk of progression to dia-
betes was reduced by 51 % compared with the control group
irrespective of obesity status at baseline (Table 1). This benefit
persisted after 20 years with an annual incidence of diabetes of
7% in the intervention group versus 11% in the control group.
That said, the 20-year cumulative incidence of diabetes in
these subjects with IGT was 80 % in the intervention groups
and 93 % in the control group, suggesting some of these sub-
jects might have benefited from earlier intervention, including
drugs to halt the progression [40••]. Despite these high cumu-
lative event rates of diabetes, after 23 years, the cumulative
incidence of cardiovascular mortality was 11.9 % in the life-
style intervention group versus 19.6 % in the control group.
The respective all-cause mortality rates were 28.1 % vs
38.4 %. These data strongly support the long-term benefits
of early intervention in people with IGT, and the need to
develop national prevention programs to identify high risk
subjects for early intervention [41].
The results of the Da Qing Study were highly consistent
with the findings of similar trials conducted in Europe and in
the United States (Table 1). In the Finnish Diabetes Prevention
Study, 522 middle-aged, overweight subjects with IGT were
randomized to receive personalized counseling for promoting
healthy lifestyle. After a mean follow-up duration of 3.2 years,
the risk of developing diabetes was reduced by 58 % in the
intervention group [42] with sustained benefits during a me-
dian follow-up period of 9 years after the trial completed [43].
In the Diabetes Prevention Program, which involved 3234
American adults with impaired fasting glycemia (IFG) or
Table 1 Effects of lifestyle
intervention on prevention of
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IGT, the incidence of diabetes was reduced by 58 % with
lifestyle intervention and 31 % with metformin after 2.8 years
of intervention, compared with the control group, irrespective
of gender and race [44]. Similarly, in another study involving
Japanese men with IGT, intensive lifestyle modification re-
duced the risk of diabetes by 67.4 % compared with the con-
trol group after 4 years [45].
These encouraging results have provided support to the
Chinese national and provincial programs to promote physical
activity and healthy eating in adults and children. In 2010, the
Ministry of Health launched a comprehensive NCD preven-
tion and control program, including health education and pro-
motion, early detection and treatment, and standardized dis-
ease management at the community level. As of 2013, 140
counties in 30 provinces of China had participated in this
national program. During this 2-year lifestyle intervention
program, there were significant improvements in the partici-
pants’ anthropometric measurements and cardiovascular risk
profiles [46]. In 2010, the school-based BTake Ten Program^
was implemented in 50 primary schools in 6 centers located in
the cities of Beijing, Shanghai, Chongqing, as well as prov-
inces of Shandong, Heilongjiang, and Guangdong. This pro-
gram mandated at least 10-minute moderate to vigorous phys-
ical activities every weekday during school attendance. In the
pilot study in Beijing involving 500 children, after 1 year of
intervention, the proportion of overweight/obese children de-
clined by 0.4 %–5.6 % compared with an increase of 0.6 %–
4.5 % in the control group [47, 48]. In 2007, the Department
of Education of Shandong Province introduced a new policy
of mandatory 1-hour physical activity in school every day. In
2010, 29,030 students aged 10–18 years participated in a sur-
vey that divided them into 2 groups (group 1 with physical
activity more than 1 h/d and group 2 less than 1 h/). After
1 year of intervention, the prevalence of obesity was 4.99 %
in group 1 and 6.62 % in group 2 for boys. The respective
figures were 1.57 % and 2.67 % in girls [49]. Given the risk
relationship between childhood obesity and diabetes in adult-
hoods, these school-based programs are likely to promote
healthy habits during formative years and is also one of the
recommended approaches by the WHO to control childhood
obesity [38].
Patient Empowerment Program
Self-management is a critical component of diabetes care,
which includes adjustment of dietary habits, regular physical
activity, foot care, self-monitoring of blood glucose and/or
urine ketone, taking oral medications and/or injecting insulin,
attending regular clinic visits, and managing emotions associ-
ated with the demands of living with diabetes [50]. These
complex lifestyle changes can be overwhelming for patients
if they are not educated, empowered, and engaged regarding
the ‘what, why, and how’ of self-management [51]. In the
second Diabetes Attitudes, Wishes, and Needs (DAWN2)
study conducted in 17 countries, a large proportion of individ-
uals with diabetes expressed lack of confidence to self-
manage in terms of changing diets, performing exercise, and
taking medications. In China, 60 % of people with diabetes
worried about the risk of hypoglycemia, 50 % had diabetes-
related distress, but only 40 % had participated in any educa-
tional program [52]. In Hong Kong, which is one of the most
cosmopolitan cities in southern China, 10 %–50 % of Chinese
type 2 diabetic patients attending hospital clinics have
depression and/or anxiety, which were associated with in-
creased risk of nonadherence, poor glycemic control, frequent
hypoglycemia, hospitalization, and cardiovascular disease
[53–57].
Amongst the many challenges of self-management faced
by patients with diabetes, lack of knowledge and empower-
ment are the two most cited barriers [58]. Acquisition of
knowledge about diabetes can facilitate self-management, es-
pecially in people with low health literacy and limited access
to diabetes education. In several systematic reviews, education
on self-management plus comprehensive lifestyle interven-
tions improved glycemic and cardiovascular risk factor con-
trol [59–61]. Apart from knowledge transfer, patient empow-
erment is needed to promote one’s ability to think critically
and act autonomously. People are empowered when they have
sufficient knowledge to make rational choices, adequate re-
sources to implement their decisions, and enough experience
to evaluate the effectiveness of their actions [62]. In this con-
nection, patients are in the best position to prioritize their self-
management strategies and make adjustments to their lives
[63]. Globally, self-management education with patient em-
powerment strategy is considered to be a key component of
diabetes management. Both the American Diabetes
Association (ADA) [64] and the United Kingdom National
Institute for Health and Clinical Excellence (NICE)
Guidelines [65] recommended provision of patient empower-
ment program upon diagnosis of diabetes
In China, several studies have confirmed the effectiveness
of self-management interventions. In a multi-center cross-sec-
tional study of 885 patients with type 2 diabetes conducted in
Nanjing, Changsha, Yunnan, and Chongqing, China, patient
empowerment was an independent predictor of improved self-
care behavior and HbA1c [66]. In Hong Kong, 1141 Chinese
patients with type 2 diabetes were enrolled into a large
community-based patient empowerment program. After
12 months, the empowerment group achieved greater reduc-
tion in HbA1c with 0.307 fewer outpatient clinic visits com-
pared with 0.507 more visits in the matched usual care group
[67]. Additionally, the empowerment group had fewer cardio-
vascular events (1.21 % vs 2.89 %) than the usual care group
[68]. The same research group expanded the study and en-
rolled 27,278 patients with type 2 diabetes without prior his-
tory of cardiovascular events into the patient empowerment
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program. After a median follow-up period of 21.5 months, the
empowerment group had a lower rate of all-cause mortality
(hazard ratio 0.564, 95 % CI 0.445–0.715) and fewer cardio-
vascular events (hazard ratio 0.807, 95 % CI 0.696–0.935)
compared with patients matched by propensity scores, includ-
ing age, sex, disease duration, and comorbidities [69].
Peer Support
Apart from receiving medical treatment from their healthcare
providers, patients with diabetes often require ongoing sup-
port to translate medical instructions into complex self-care
behaviors on a daily basis. By providing informational and
emotional support through mutual identification, shared expe-
riences, and increased sense of belonging, peer support has
been shown to improve physical and psychological health
outcomes. A large number of studies now show that peer
support helped patients with diabetes increase physical activ-
ity [70, 71], perform self-monitoring of blood glucose [72],
adhere to balanced diet [70, 73, 74], and initiate insulin ther-
apy [75]. Peer support has also been shown to improve control
of blood glucose [72, 75, 76], blood pressure [77], and blood
cholesterol [73], as well as reduce body weight [74] and hy-
poglycemia [70, 72].
In China, several studies have confirmed the efficacy of
peer support in diabetes management. In a pragmatic random-
ized study involving 3 cities in Anhui Province, within each
city, patients in one community were assigned to receive peer
support, and in the other community, usual care. The peer
supporters were trained by the primary care clinical team
and instructed to contact patients within their residential set-
tings. Peer support was well-received, resulting in better dia-
betes knowledge, self-efficacy, blood pressure, and glucose
control [78]. In another randomized trial involving 208 pa-
tients with type 2 diabetes receiving community-based insulin
therapy in rural China, patients with peer support achieved
greater reduction in HbA1c (0.60 % vs 0.32 %), knowledge
of insulin usage, and self-management compared with patients
with usual care [79]. In a randomized study in Hong Kong,
628 patients with type 2 diabetes who received multi-
component integrated care (structured assessment, risk strati-
fication, personalized reporting with decision support, and
group empowerment by nurses) were randomized to receive
telephone-based peer support for 1 year. Peer support did not
further improve control of cardio-metabolic risk factors con-
trol but significantly reduced hospitalization [57].
Furthermore, patients who continued to provide peer support
to others had better self-care with sustained optimal glycemic
control during the 4-year post-trial period than those who de-
cided to quit as peer-supporters after 1 year of the intervention
program [80].
People who have to live with lifelong diseases often feel
isolated from their network of friends, families, and
coworkers, who may not fully understand or empathize with
their daily challenges. By sharing their experiences and dis-
closing their feelings in a warm, sympathetic, and accepting
manner, the peer supporters can help their peers to discuss
their thoughts and express concerns. With this emotional sup-
port, people may change their negative appraisal of life events
and gain confidence with reduced negative emotions and in-
creased treatment adherence [81]. Studies have shown that
patients with diabetes perceived increased social support after
receiving peer support [73, 75]. The potential impacts of these
psychosocial–behavioral interventions on health care out-
comes and utilizations may be under-recognized. In the afore-
mentioned study of 628 Hong Kong Chinese patients with
type 2 diabetes, integrated care and group empowerment im-
proved medication adherence, self-care, and self-efficacy,
while reducing negative emotions. Within the peer support
group, patients with negative emotions benefited most from
peer support with improved psychological health and treat-
ment adherence, which might contribute towards the reduced
hospitalization rates [57]. These findings highlight the plural-
istic needs of patients with complex disease like diabetes,
which require medical care, education, technology, and emo-
tional support. To this end, empowerment and peer support are
recommended strategies by the WHO for prevention and con-
trol of diabetes [82].
Care Integration
Variation and fragmentation in healthcare systems are major
barriers in effective diabetes management due to phenotypic
heterogeneity, complex care protocols, variable standards in
clinical expertise, and care provision, compounded by lack of
coordination between different levels and settings of care. As
a result, diabetic patients often experience difficulty in navi-
gating the health care system with poor care continuity, irra-
tional and inefficient use of resources, unnecessarily expen-
sive interventions, and dissatisfaction of user experiences [83,
84]. The causes of fragmentation vary from one region to
another although common causes include institutional seg-
mentation, decentralized administrative entities, disease-
specific treatment plans with insufficient coordination, lack
of personalized care, and imbalanced resource allocation with
priority often given to acute or episodic care [85].
In China, most diabetologists practice in tertiary hospitals
whereas primary care physicians, who are more accessible and
care for the majority of patients with diabetes, only have a
basic knowledge of diabetes. Patients in rural areas have very
limited access to comprehensive diabetes assessment, which is
mainly provided by diabetologists. In the urban areas, patients
often visit multiple hospitals, resulting in both gaps and dupli-
cation in service provision. China is a large country with dif-
ferent stages of rural-urban transition and variable insurance
coverage in different provinces and cities. Despite their
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determination to reform the health care system with universal
health coverage [86], the Chinese authorities face huge chal-
lenges in transforming the long-standing but inefficient, ex-
pensive, and fragmented hospital-centric system into one that
delivers community-based, high-quality integrated care to ad-
dress the multiple health care needs associated with urbaniza-
tion in an aging society [87, 88].
To tackle these problems, experts advocated the use of a
multidisciplinary approach to provide comprehensive and coor-
dinated health care to a defined population [89, 90]. From the
care provider’s perspective, integrated caremay improve clinical
effectiveness, responsiveness, acceptability, and efficiency [91,
92]. From the patient’s point of view, integrated care can facil-
itate timely access to care, prevent service duplication, improve
shared decision-making, and promote self-care strategies [93].
In 2007, using state of the art information technology, re-
searchers in Hong Kong designed the first web-based compre-
hensive diabetes management program, known as the Joint Asia
Diabetes Evaluation (JADE) Program. This program advocates
change of workflow and uses trained nurses, under medical
supervision, to implement a multi-component quality improve-
ment program in accordance with international practice guide-
lines [94]. It aims to facilitate delivery of multidisciplinary and
coordinated care by specialists, family physicians, nurses, dieti-
tians, podiatrists, community health workers, and trained non-
physician personnel, and establish a registry for quality
assurance. In order to manage the large amount of clinical in-
formation during the clinical course of diabetes, the JADEportal
incorporates (1) templates to guide standardized clinical assess-
ment and data capture for risk categorization; (2) validated risk
equations to estimate 5-year probabilities of major clinical
events; (3) personalized feedback reports with diagrams, secular
trends, and bar charts indicating risk profiles, target values, and
risk factors control; and (4) individualized decision support for
both doctors and patients, triggered by attained target ABC
values [glycated hemoglobin (HbA1c), blood pressure (BP),
and LDL-cholesterol (LDL-C)] and body weight, to empower
self-management, reduce clinical inertia, and promote shared
decision-making (Fig. 1) [95•].
The JADE Program has provided a care prototype that is
highly relevant to this information era where electronic med-
ical systems are increasingly used in both developed and de-
veloping countries and areas. These new technologies have
enabled healthcare providers to systematically collect, inte-
grate, interpret, and communicate relevant information to ed-
ucate, engage, and empower patients. It also provides a sus-
tainable platform to conduct multicenter research projects in a
real-world setting for evaluating interventions. In a 6-center
study in China with each center enrolling 600 patients, each
center was given a nurse and clerk to perform comprehensive
assessment augmented by the JADE portal with half of them
being contacted by their nurse at least twice. After 1 year, there
Fig. 1 Conceptual framework
depicting how integrated care
implemented through the Joint
Asia Diabetes Evaluation (JADE)
Program enabled by a web-based
portal might improve outcomes in
patients with diabetes
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was significant improvement in risk factor control in both
groups, with patients receiving additional nurse support hav-
ing better self care and less likely to default at 1 year [96].
Using the JADE portal to collect and share information, to-
gether with patient empowerment and peer support programs,
researchers in Hong Kong have demonstrated the benefits of
this holistic care model on glycemic control [97], medication
adherence, self-care activities, and psychological well-being
in people with diabetes [57].
In a 2-year, case-control study involving 160 Chinese patients
with diabetic nephropathy, patients who received structured care
implemented by a pharmacist-diabetes specialist team with par-
ticular emphasis on periodic laboratory assessments, patient ad-
herence, risk factors control, and use of renin angiotensin system
(RAS) inhibitors reduced the incidence of end stage renal disease
and all-cause death by over 55% and 78%, respectively [98]. In
another multicenter randomized study involving 205 Chinese
patients with type 2 diabetes and renal impairment, more patients
in the structured care group attained multiple treatment targets,
which were translated to 60 %–70 % risk reduction in premature
death and end stage renal disease [99]. In 2009, the Hong Kong
Hospital Authority, which manages all public hospitals and
clinics in Hong Kong, introduced the Multidisciplinary Risk
Assessment and Management Program for Patients with
Diabetes Mellitus (RAMP-DM) to evaluate the effectiveness of
a multidisciplinary risk-stratification program on metabolic out-
comes and cardiovascular events in patients with diabetes within
a primary care setting [68]. Compared with a matched cohort
adjusted for propensity score, 1248 Chinese type 2 diabetic pa-
tients had greater improvements in HbA1c and reduction in car-
diovascular risks after receiving 12 months of RAMP-DM.
Similarly, 1141 patients with type 2 diabetes received a
territory-wide patient-empowerment program (PEP) delivered
by non-government organizations [67]. During a 12-month ob-
servation period, compared with a matched group under usual
care, PEP did not further improve clinical outcomes but reduced
health service utilization [67]. These encouraging results have led
the Hong Kong Hospital Authority to adopt integrated diabetes
care as a corporate strategy. This includes creation of diabetes
centers and career track for diabetes specialist nurses for estab-
lishing a territory-wide diabetes registry through periodic com-
prehensive assessment, followed by care triage, patient empow-
erment, and peer support.
Conclusions
The causes of the diabetes epidemic in China are complex.
These include heterogeneity of genetic, epigenetic, and life-
style factors against a backdrop of a rapidly changing society
with transitions of cultures, behaviors, and environments. In
order to meet the medical, social, educational, and emotional
needs of these patients, there is a need to establish a holistic
care model through multisectorial partnerships for improving
quality of care and reducing adverse clinical outcomes. Apart
from using information technology to integrate different med-
ical care components with periodic comprehensive assess-
ments, patient empowerment, and peer support are affordable
strategies that can be incorporated into such care models. In
line with the WHO recommendation, creating a health-
enabling environment using public policies, (eg, tobacco con-
trol, taxation on sweetened sugar beverages, maternal and
child health, environment protection, promoting health litera-
cy, reducing childhood obesity) and strengthening the health
care system to provide integrated care, through community
empowerment and multisectoral partnerships, hold the keys
to success in our common fight to prevent and control diabetes
[88].
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